Argenx SE
ARGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001697862
No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.
Superinvestors holding ARGX, Q2 2026
No superinvestor reported holding ARGX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ARGX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q1 2024
1 superinvestor holding at quarter end
Q4 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q3 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−10.2%)
Q2 2023
1 superinvestor holding at quarter end
Q2 2022
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−66.4%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−4.9%)
- Sold out
- Lone Pine Capital